KLENCKE BARBARA enters ALX ONCOLOGY HOLDINGS INC with 120K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 3/5/2026ACC: 0001193125-26-093894
Officer· Chief Medical Officer
Since Feb 2026
120K
Baseline shares
50% direct
60K
Direct ownership
1 position
440.40K
Derivative underlying
3 instruments
2
Security positions
60K indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned60K
Common Stock
DirectShares owned60K
Total
60K direct·60K indirect120K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 60K | Indirect |
| Common Stock | 60K | Direct |
| Total | 120K | 60K direct·60K indirect |
Derivative Holdings3
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
40.40K
Shares owned
N/A
Exercise price
1.65
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
300K
Shares owned
N/A
Exercise price
1.05
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
1.48
Expiration
—
Exercise window
—
Total
Underlying
440.40K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock | 1.65 | — | — | 40.40K | N/A |
| Stock option (right to buy) Direct | Common Stock | 1.05 | — | — | 300K | N/A |
| Stock option (right to buy) Direct | Common Stock | 1.48 | — | — | 100K | N/A |
| Total | 440.40K | 0.00 | ||||